{"filing":{"accession_number":"0001104659-26-065158","cik":"0000888491","ticker":"OHI","company_name":"OMEGA HEALTHCARE INVESTORS INC","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"tm2615007d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/888491/000110465926065158/tm2615007d1_8k.htm"},"events":[{"id":730,"run_id":629,"accession_number":"0001104659-26-065158","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"C. Taylor Pickett (CEO) and Robert O. Stephenson (CFO) are departing the company, effective October 1, 2026 and August 1, 2026 respectively. The filing discloses transition and consulting agreements for both executives, representing a material change in the company's top leadership.","company_name":"OMEGA HEALTHCARE INVESTORS INC","ticker":"OHI","filing_date":"2026-05-21","items":[{"id":940,"accession_number":"0001104659-26-065158","item_number":"5.02","item_title":"Departure","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the departure of two senior executives: C. Taylor Pickett (CEO) terminating effective October 1, 2026, and Robert O. Stephenson (CFO) terminating effective August 1, 2026. While the filing also announces successor appointments (Matthew P. Gourmand as CEO and Neal A. Ballew as CFO), the principal disclosed action centers on the departures of these named executives, supported by detailed transition and consulting agreements. This is material to investors as it involves the top two leadership positions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:33:19.832006+00:00","company_name":"","ticker":null,"filing_date":""},{"id":941,"accession_number":"0001104659-26-065158","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"The Item 7.01 disclosure references \"executive transitions described above\" but the actual content of those transitions is not provided in this section. The filing indicates a press release was issued announcing executive transitions (Exhibit 99.1), which typically signals either exec_departure or exec_appointment. However, without access to the substantive details of the transitions themselves, the most defensible classification is other_material, as executive transitions are inherently material but the specific nature (departure vs. appointment vs. compensation change) cannot be determined from this boilerplate disclosure language alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:33:19.832006+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":940,"accession_number":"0001104659-26-065158","item_number":"5.02","item_title":"Departure","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the departure of two senior executives: C. Taylor Pickett (CEO) terminating effective October 1, 2026, and Robert O. Stephenson (CFO) terminating effective August 1, 2026. While the filing also announces successor appointments (Matthew P. Gourmand as CEO and Neal A. Ballew as CFO), the principal disclosed action centers on the departures of these named executives, supported by detailed transition and consulting agreements. This is material to investors as it involves the top two leadership positions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:33:19.832006+00:00","company_name":"OMEGA HEALTHCARE INVESTORS INC","ticker":"OHI","filing_date":"2026-05-21"},{"id":941,"accession_number":"0001104659-26-065158","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"The Item 7.01 disclosure references \"executive transitions described above\" but the actual content of those transitions is not provided in this section. The filing indicates a press release was issued announcing executive transitions (Exhibit 99.1), which typically signals either exec_departure or exec_appointment. However, without access to the substantive details of the transitions themselves, the most defensible classification is other_material, as executive transitions are inherently material but the specific nature (departure vs. appointment vs. compensation change) cannot be determined from this boilerplate disclosure language alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:33:19.832006+00:00","company_name":"OMEGA HEALTHCARE INVESTORS INC","ticker":"OHI","filing_date":"2026-05-21"}]}